Log in
E-mail
Password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
Settings
Settings
Dynamic quotes 
OFFON

4-Traders Homepage  >  Equities  >  London Stock Exchange  >  GlaxoSmithKline plc    GSK   GB0009252882

SummaryQuotesChartsNewsAnalysisCalendarCompanyFinancialsConsensusRevisions 
News SummaryMost relevantAll newsSector newsTweets 

GlaxoSmithKline plc : Director/PDMR Shareholding

share with twitter share with LinkedIn share with facebook
share via e-mail
0
05/03/2012 | 08:11pm CET

Notification of Transactions of Directors, Persons Discharging Managerial Responsibility or Connected Persons

I give below details of changes in the interests of a Person Discharging Managerial Responsibility in the Ordinary Shares of GlaxoSmithKline plc ("Ordinary Shares") on 2 May 2012:

Mr S M Bicknell

Transfer of 250 Ordinary Shares into an ISA at £14.3225 per share.



The Company and the above mentioned person was advised of this transaction on 3 May 2012.

This notification relates to a transaction notified in accordance with Disclosure Rule 3.1.4R(1)(a).

V A Whyte

Company Secretary

3 May 2012


This information is provided by RNS
The company news service from the London Stock Exchange
ENDRDSQXLFBLEFXBBD
distributed by
share with twitter share with LinkedIn share with facebook
share via e-mail
0
Latest news on GLAXOSMITHKLINE PLC
02/24 JUSTIFICATION AND APPROVAL - 65-- RE : 00173-0681-22
02/23DJGlaxoSmithKline Reports Positive Study Results for Asthma Drug
02/23 GLAXOSMITHKLINE : Positive results for Relvar Ellipta Lung Study
02/23 GLAXOSMITHKLINE : Glaxo Gets Positive Headline Results On Relvar-Ellipta Asthma ..
02/23 GLAXOSMITHKLINE : Positive Results for Relvar® Ellipta® Lung Function Study in P..
02/23 GLAXOSMITHKLINE : Positive results for Relvar® Ellipta® lung function study in p..
02/23DJPURETECH HEALTH : Appoints Atul Pande as Chief Medical Officer
02/23 GLAXOSMITHKLINE PLC : ex-dividend day for final dividend
02/21 KORN FERRY : Futurestep Partners with GlaxoSmithKline to Support Talent Acquisit..
02/17 European shares retreat after week of gains; Allianz rallies after update
More news
Sector news : Pharmaceuticals - NEC
08:06aDJSANOFI : Lonza to Invest CHF290 Million in New Plant in Switzerland
02/24DJSHIRE : Files 8K - Other Events
02/24DJASTRAZENECA : Hyperkalaemia Drug Clears Scientific Hurdle for European Approval
02/24DJASTRAZENECA : Gets Approval for Drug Treating Hyperkalaemia
02/24 Exclusive - Trump says Republican border tax could boost U.S. jobs
More sector news : Pharmaceuticals - NEC
News from SeekingAlpha
02/26 BIOTECH FORUM DAILY DIGEST : Can Aerie Pharmaceuticals Continue To Rally? Spotli..
02/24 I'M SICK AND TIRED OF GILEAD SCIENCE : Part 2
02/24 GILEAD : No HCV? No Problem
02/23 GlaxoSmithKline's Valuation Is Compelling
02/23 Glaxo's once-daily Relvar Ellipta matches twice-daily Seretide Accuhaler in l..
Advertisement
Financials ( GBP)
Sales 2017 29 948 M
EBIT 2017 8 405 M
Net income 2017 4 175 M
Debt 2017 13 565 M
Yield 2017 4,88%
P/E ratio 2017 20,29
P/E ratio 2018 17,01
EV / Sales 2017 3,14x
EV / Sales 2018 3,01x
Capitalization 80 506 M
More Financials
Chart GLAXOSMITHKLINE PLC
Duration : Period :
GlaxoSmithKline plc Technical Analysis Chart | GSK | GB0009252882 | 4-Traders
Full-screen chart
Technical analysis trends GLAXOSMITHKLINE PLC
Short TermMid-TermLong Term
TrendsBullishNeutralNeutral
Technical analysis
Income Statement Evolution
More Financials
Consensus
Sell
Buy
Mean consensus OUTPERFORM
Number of Analysts 29
Average target price 17,7  GBP
Spread / Average Target 7,9%
Consensus details
EPS Revisions
More Estimates Revisions
Managers
NameTitle
Andrew Philip Witty Chief Executive Officer & Executive Director
Philip Roy Hampton Non-Executive Chairman
Simon Dingemans Chief Financial Officer & Executive Director
Birgitte Volck Head-Research & Development
Moncef Slaoui Executive Director & Chairman-Global Vaccines
More about the company
Sector and Competitors
1st jan.Capitalization (M$)
GLAXOSMITHKLINE PLC4.96%100 321
JOHNSON & JOHNSON6.53%333 891
ROCHE HOLDING LTD.5.42%210 192
PFIZER INC.5.48%207 902
NOVARTIS AG4.72%202 648
MERCK & CO., INC.12.38%182 412
More Results